Table 2 Follow-up and the fate of managed patients
Hepatectomy (N = 31) | Percutaneous microwave (N = 37) | Intraoperative microwave (N = 4) | P value | ||
|---|---|---|---|---|---|
Response to treatment (according to mRECIST) (count/%) | |||||
• Complete response | 29 (93.6%) | 30 (81.1%) | 3 (75%) | 0.331 | |
• Partial response | 2 (6.4%) | 5 (13.5%) | 1 (25%) | ||
• Stationary disease | 0 (0%) | 2 (5.4%) | 0 (0%) | ||
• Progressive disease | 0 (0%) | 0 (0%) | 0 (0%) | ||
Recurrence and progression (count/%) | |||||
• Recurrence | 3 (9.7%) | 3 (8.1%) | 0 (0%) | 0.733 | |
• Portal vein thrombosis | Yes | 0 (0%) | 1 (2.4%) | 1 | |
No | 31 (100%) | 40 (97.6%) | |||
• Lymph node deposits | Yes | 2 (6.5%) | 0 (0%) | 0.182 | |
No | 29 (93.5%) | 41 (100%) | |||
Clinical decompensation (mean/SD) | 5 (16.1%) | 5 (13.5%) | 1 (25%) | 0.656 | |
New ascites | Yes | 1 (3.2%) | 0 (0%) | 0.431 | |
No | 30 (96.8%) | 41 (100%) | |||
Mortality | 7 (22.6%) | 13 (35.1%) | 1 (25%) | 0.545 | |